Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Bio-MEMS Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Bio-MEMS Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 145 Pages
Report ld: 4807706
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Bio-MEMS Market Size(US$)
CAGR 2025-2031
9.4%
Market Size,2031
USD 10,330
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,044 million
Market Forecast in 2031(Value)
US$ 10,330 million
CAGR
9.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Bio-MEMS market is projected to grow from US$ 5575 million in 2024 to US$ 10330 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Bio-MEMS is an abbreviation for biomedical (or biological) microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single (often microfluidic) chips.
Global key players of Bio-MEMS include Danaher, Thermo Fisher Scientific and Roche, etc. Global top three manufacturers hold a share over 40%. North America is the largest market of Bio-MEMS, with a share over 50%, followed by Europe and Asia-Pacific.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bio-MEMS market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Danaher
- Thermo Fisher Scientific
- Roche
- Illumina
- Abbott Laboratories
- PerkinElmer
- Agilent Technologies
- Bio-Rad Laboratories
- Amphenol
- TE Connectivity
- bioMérieux(BioFire)
- Merit Medical
- Standard BioTools
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Biochip
- MEMS Biosensor
- Others
Segment by Application
- In Vitro Devices
- In Vivo Devices
CHAPTER OUTLINE
Chapter 1: Defines the Bio-MEMS study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Bio-MEMS: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bio-MEMS Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biochip
1.2.3 MEMS Biosensor
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Bio-MEMS Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 In Vitro Devices
1.3.3 In Vivo Devices
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bio-MEMS Revenue Estimates and Forecasts 2020-2031
2.2 Global Bio-MEMS Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bio-MEMS Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bio-MEMS Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biochip Market Size by Players
3.3.2 MEMS Biosensor Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Bio-MEMS Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bio-MEMS Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bio-MEMS Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bio-MEMS Market Size by Type (2020-2031)
6.4 North America Bio-MEMS Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bio-MEMS Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bio-MEMS Market Size by Type (2020-2031)
7.4 Europe Bio-MEMS Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bio-MEMS Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bio-MEMS Market Size by Type (2020-2031)
8.4 Asia-Pacific Bio-MEMS Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bio-MEMS Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bio-MEMS Market Size by Type (2020-2031)
9.4 Central and South America Bio-MEMS Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bio-MEMS Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bio-MEMS Market Size by Type (2020-2031)
10.4 Middle East and Africa Bio-MEMS Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bio-MEMS Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Danaher
11.1.1 Danaher Corporation Information
11.1.2 Danaher Business Overview
11.1.3 Danaher Bio-MEMS Product Features and Attributes
11.1.4 Danaher Bio-MEMS Revenue and Gross Margin (2020-2025)
11.1.5 Danaher Bio-MEMS Revenue by Product in 2024
11.1.6 Danaher Bio-MEMS Revenue by Application in 2024
11.1.7 Danaher Bio-MEMS Revenue by Geographic Area in 2024
11.1.8 Danaher Bio-MEMS SWOT Analysis
11.1.9 Danaher Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Bio-MEMS Product Features and Attributes
11.2.4 Thermo Fisher Scientific Bio-MEMS Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific Bio-MEMS Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific Bio-MEMS Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific Bio-MEMS Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific Bio-MEMS SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Business Overview
11.3.3 Roche Bio-MEMS Product Features and Attributes
11.3.4 Roche Bio-MEMS Revenue and Gross Margin (2020-2025)
11.3.5 Roche Bio-MEMS Revenue by Product in 2024
11.3.6 Roche Bio-MEMS Revenue by Application in 2024
11.3.7 Roche Bio-MEMS Revenue by Geographic Area in 2024
11.3.8 Roche Bio-MEMS SWOT Analysis
11.3.9 Roche Recent Developments
11.4 Illumina
11.4.1 Illumina Corporation Information
11.4.2 Illumina Business Overview
11.4.3 Illumina Bio-MEMS Product Features and Attributes
11.4.4 Illumina Bio-MEMS Revenue and Gross Margin (2020-2025)
11.4.5 Illumina Bio-MEMS Revenue by Product in 2024
11.4.6 Illumina Bio-MEMS Revenue by Application in 2024
11.4.7 Illumina Bio-MEMS Revenue by Geographic Area in 2024
11.4.8 Illumina Bio-MEMS SWOT Analysis
11.4.9 Illumina Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Corporation Information
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Bio-MEMS Product Features and Attributes
11.5.4 Abbott Laboratories Bio-MEMS Revenue and Gross Margin (2020-2025)
11.5.5 Abbott Laboratories Bio-MEMS Revenue by Product in 2024
11.5.6 Abbott Laboratories Bio-MEMS Revenue by Application in 2024
11.5.7 Abbott Laboratories Bio-MEMS Revenue by Geographic Area in 2024
11.5.8 Abbott Laboratories Bio-MEMS SWOT Analysis
11.5.9 Abbott Laboratories Recent Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Corporation Information
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Bio-MEMS Product Features and Attributes
11.6.4 PerkinElmer Bio-MEMS Revenue and Gross Margin (2020-2025)
11.6.5 PerkinElmer Recent Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Corporation Information
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Bio-MEMS Product Features and Attributes
11.7.4 Agilent Technologies Bio-MEMS Revenue and Gross Margin (2020-2025)
11.7.5 Agilent Technologies Recent Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Corporation Information
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Bio-MEMS Product Features and Attributes
11.8.4 Bio-Rad Laboratories Bio-MEMS Revenue and Gross Margin (2020-2025)
11.8.5 Bio-Rad Laboratories Recent Developments
11.9 Amphenol
11.9.1 Amphenol Corporation Information
11.9.2 Amphenol Business Overview
11.9.3 Amphenol Bio-MEMS Product Features and Attributes
11.9.4 Amphenol Bio-MEMS Revenue and Gross Margin (2020-2025)
11.9.5 Amphenol Recent Developments
11.10 TE Connectivity
11.10.1 TE Connectivity Corporation Information
11.10.2 TE Connectivity Business Overview
11.10.3 TE Connectivity Bio-MEMS Product Features and Attributes
11.10.4 TE Connectivity Bio-MEMS Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 bioMérieux(BioFire)
11.11.1 bioMérieux(BioFire) Corporation Information
11.11.2 bioMérieux(BioFire) Business Overview
11.11.3 bioMérieux(BioFire) Bio-MEMS Product Features and Attributes
11.11.4 bioMérieux(BioFire) Bio-MEMS Revenue and Gross Margin (2020-2025)
11.11.5 bioMérieux(BioFire) Recent Developments
11.12 Merit Medical
11.12.1 Merit Medical Corporation Information
11.12.2 Merit Medical Business Overview
11.12.3 Merit Medical Bio-MEMS Product Features and Attributes
11.12.4 Merit Medical Bio-MEMS Revenue and Gross Margin (2020-2025)
11.12.5 Merit Medical Recent Developments
11.13 Standard BioTools
11.13.1 Standard BioTools Corporation Information
11.13.2 Standard BioTools Business Overview
11.13.3 Standard BioTools Bio-MEMS Product Features and Attributes
11.13.4 Standard BioTools Bio-MEMS Revenue and Gross Margin (2020-2025)
11.13.5 Standard BioTools Recent Developments
12 Bio-MEMSIndustry Chain Analysis
12.1 Bio-MEMS Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bio-MEMS Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bio-MEMS Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Bio-MEMS Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bio-MEMS Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bio-MEMS Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bio-MEMS Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bio-MEMS Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Bio-MEMS Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Bio-MEMS Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Bio-MEMS by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio-MEMS as of 2024)
Table 11. Global Bio-MEMS Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Bio-MEMS Companies Headquarters
Table 13. Global Bio-MEMS Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Bio-MEMS Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Bio-MEMS Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Bio-MEMS Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Bio-MEMS Revenue by Application (2026-2031) & (US$ Million)
Table 21. Bio-MEMS High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Bio-MEMS Growth Accelerators and Market Barriers
Table 25. North America Bio-MEMS Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Bio-MEMS Growth Accelerators and Market Barriers
Table 27. Europe Bio-MEMS Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Bio-MEMS Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Bio-MEMS Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Bio-MEMS Investment Opportunities and Key Challenges
Table 31. Central and South America Bio-MEMS Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Bio-MEMS Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Bio-MEMS Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Danaher Corporation Information
Table 35. Danaher Description and Major Businesses
Table 36. Danaher Product Features and Attributes
Table 37. Danaher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Danaher Revenue Proportion by Product in 2024
Table 39. Danaher Revenue Proportion by Application in 2024
Table 40. Danaher Revenue Proportion by Geographic Area in 2024
Table 41. Danaher Bio-MEMS SWOT Analysis
Table 42. Danaher Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific Bio-MEMS SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. Roche Corporation Information
Table 53. Roche Description and Major Businesses
Table 54. Roche Product Features and Attributes
Table 55. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Roche Revenue Proportion by Product in 2024
Table 57. Roche Revenue Proportion by Application in 2024
Table 58. Roche Revenue Proportion by Geographic Area in 2024
Table 59. Roche Bio-MEMS SWOT Analysis
Table 60. Roche Recent Developments
Table 61. Illumina Corporation Information
Table 62. Illumina Description and Major Businesses
Table 63. Illumina Product Features and Attributes
Table 64. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Illumina Revenue Proportion by Product in 2024
Table 66. Illumina Revenue Proportion by Application in 2024
Table 67. Illumina Revenue Proportion by Geographic Area in 2024
Table 68. Illumina Bio-MEMS SWOT Analysis
Table 69. Illumina Recent Developments
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Major Businesses
Table 72. Abbott Laboratories Product Features and Attributes
Table 73. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Abbott Laboratories Revenue Proportion by Product in 2024
Table 75. Abbott Laboratories Revenue Proportion by Application in 2024
Table 76. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
Table 77. Abbott Laboratories Bio-MEMS SWOT Analysis
Table 78. Abbott Laboratories Recent Developments
Table 79. PerkinElmer Corporation Information
Table 80. PerkinElmer Description and Major Businesses
Table 81. PerkinElmer Product Features and Attributes
Table 82. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. PerkinElmer Recent Developments
Table 84. Agilent Technologies Corporation Information
Table 85. Agilent Technologies Description and Major Businesses
Table 86. Agilent Technologies Product Features and Attributes
Table 87. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Agilent Technologies Recent Developments
Table 89. Bio-Rad Laboratories Corporation Information
Table 90. Bio-Rad Laboratories Description and Major Businesses
Table 91. Bio-Rad Laboratories Product Features and Attributes
Table 92. Bio-Rad Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Bio-Rad Laboratories Recent Developments
Table 94. Amphenol Corporation Information
Table 95. Amphenol Description and Major Businesses
Table 96. Amphenol Product Features and Attributes
Table 97. Amphenol Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Amphenol Recent Developments
Table 99. TE Connectivity Corporation Information
Table 100. TE Connectivity Description and Major Businesses
Table 101. TE Connectivity Product Features and Attributes
Table 102. TE Connectivity Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. TE Connectivity Recent Developments
Table 104. bioMérieux(BioFire) Corporation Information
Table 105. bioMérieux(BioFire) Description and Major Businesses
Table 106. bioMérieux(BioFire) Product Features and Attributes
Table 107. bioMérieux(BioFire) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. bioMérieux(BioFire) Recent Developments
Table 109. Merit Medical Corporation Information
Table 110. Merit Medical Description and Major Businesses
Table 111. Merit Medical Product Features and Attributes
Table 112. Merit Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Merit Medical Recent Developments
Table 114. Standard BioTools Corporation Information
Table 115. Standard BioTools Description and Major Businesses
Table 116. Standard BioTools Product Features and Attributes
Table 117. Standard BioTools Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Standard BioTools Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-MEMS Product Picture
Figure 2. Global Bio-MEMS Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biochip Product Picture
Figure 4. MEMS Biosensor Product Picture
Figure 5. Others Product Picture
Figure 6. Global Bio-MEMS Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. In Vitro Devices
Figure 8. In Vivo Devices
Figure 9. Bio-MEMS Report Years Considered
Figure 10. Global Bio-MEMS Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 12. Global Bio-MEMS Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Bio-MEMS Revenue Market Share by Region (2020-2031)
Figure 14. Global Bio-MEMS Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Biochip Revenue Market Share by Player in 2024
Figure 17. MEMS Biosensor Revenue Market Share by Player in 2024
Figure 18. Others Revenue Market Share by Player in 2024
Figure 19. Global Bio-MEMS Revenue Market Share by Type (2020-2031)
Figure 20. Global Bio-MEMS Revenue Market Share by Application (2020-2031)
Figure 21. North America Bio-MEMS Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Bio-MEMS Revenue (US$ Million) in 2024
Figure 23. North America Bio-MEMS Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Bio-MEMS Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Bio-MEMS Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Bio-MEMS Revenue (US$ Million) in 2024
Figure 30. Europe Bio-MEMS Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Bio-MEMS Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 33. France Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Bio-MEMS Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Bio-MEMS Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Bio-MEMS Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Bio-MEMS Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 45. India Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Bio-MEMS Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Bio-MEMS Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Bio-MEMS Revenue (US$ Million) in 2024
Figure 53. Central and South America Bio-MEMS Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Bio-MEMS Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Bio-MEMS Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Bio-MEMS Revenue (US$ Million) in 2024
Figure 59. South America Bio-MEMS Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Bio-MEMS Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Bio-MEMS Revenue (2020-2025) & (US$ Million)
Figure 65. Bio-MEMS Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.4% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Bio-MEMS market size from 2025 to 2031?
Which companies rank high in the global Bio-MEMS market?
What was the global market size of Bio-MEMS in 2031?
What was the global market size of Bio-MEMS in 2025?
Related Reports
Global Bio-MEMS Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bio-MEMS market size was US$ 6044 million in 2025 and is forecast to reach a readjusted size of US$ 11200 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 100
USD 4250.00
(Single User License)
Global Bio-MEMS Market Research Report 2026
The global Bio-MEMS market was valued at US$ 6044 million in 2025 and is anticipated to reach US$ 11200 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 2900.00
(Single User License)
Bio-MEMS - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-MEMS was estimated to be worth US$ 6044 million in 2025 and is projected to reach US$ 11200 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Bio-MEMS Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-MEMS market size was US$ 5575 million in 2024 and is forecast to a readjusted size of US$ 10330 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 92
USD 4250.00
(Single User License)
Bio-MEMS- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-MEMS was estimated to be worth US$ 5575 million in 2024 and is forecast to a readjusted size of US$ 10330 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 119
USD 3950.00
(Single User License)
Global Bio-MEMS Market Research Report 2025
The global market for Bio-MEMS was valued at US$ 5575 million in the year 2024 and is projected to reach a revised size of US$ 10330 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published Date: 2025-01-19
Pages: 84
USD 2900.00
(Single User License)
Bio-MEMS - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-MEMS is an abbreviation for biomedical (or biological) microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single (often microfluidic) chips.
Published Date: 2024-01-18
Pages: 108
USD 3950.00
(Single User License)
Global Bio-MEMS Market Research Report 2024
Bio-MEMS is an abbreviation for biomedical (or biological) microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single (often microfluidic) chips.
Published Date: 2024-01-03
Pages: 83
USD 2900.00
(Single User License)
Global Bio-MEMS Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bio-MEMS market size was US$ 6044 million in 2025 and is forecast to reach a readjusted size of US$ 11200 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 100
USD 4250.00 (Single User License)Global Bio-MEMS Market Research Report 2026
The global Bio-MEMS market was valued at US$ 6044 million in 2025 and is anticipated to reach US$ 11200 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
USD 2900.00 (Single User License)Bio-MEMS - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-MEMS was estimated to be worth US$ 6044 million in 2025 and is projected to reach US$ 11200 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)Global Bio-MEMS Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-MEMS market size was US$ 5575 million in 2024 and is forecast to a readjusted size of US$ 10330 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 92
USD 4250.00 (Single User License)Bio-MEMS- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-MEMS was estimated to be worth US$ 5575 million in 2024 and is forecast to a readjusted size of US$ 10330 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 119
USD 3950.00 (Single User License)Global Bio-MEMS Market Research Report 2025
The global market for Bio-MEMS was valued at US$ 5575 million in the year 2024 and is projected to reach a revised size of US$ 10330 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published: 2025-01-19
Pages: 84
USD 2900.00 (Single User License)Bio-MEMS - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-MEMS is an abbreviation for biomedical (or biological) microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single (often microfluidic) chips.
Published: 2024-01-18
Pages: 108
USD 3950.00 (Single User License)Global Bio-MEMS Market Research Report 2024
Bio-MEMS is an abbreviation for biomedical (or biological) microelectromechanical systems. Bio-MEMS have considerable overlap, and is sometimes considered synonymous, with lab-on-a-chip (LOC) and micro total analysis systems (μTAS). Bio-MEMS is typically more focused on mechanical parts and microfabrication technologies made suitable for biological applications. On the other hand, lab-on-a-chip is concerned with miniaturization and integration of laboratory processes and experiments into single (often microfluidic) chips.
Published: 2024-01-03
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now